Welcome to our dedicated page for Semler Scientific SEC filings (Ticker: SMLR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Semler Scientific, Inc. (Nasdaq: SMLR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. These documents cover both its healthcare operations and its Bitcoin treasury activities, offering investors insight into how the company reports revenues and expenses from its medical device and software business alongside unrealized gains and losses from changes in the fair value of its Bitcoin holdings.
In its periodic reports, Semler Scientific presents financial statements that reflect income from operations in its healthcare segment, operating expenses such as engineering and product development, sales and marketing, and general and administrative costs, as well as line items related to digital assets. The filings detail the fair value of Bitcoin classified as intangible digital assets, changes in that fair value, and the impact on pre-tax income. They also describe capital-raising transactions, including at-the-market equity offering programs and 4.25% convertible senior notes due 2030, and provide information on stockholders’ equity.
Current reports on Form 8-K document material events such as the adoption and evolution of Semler Scientific’s Bitcoin treasury strategy, the master loan agreement with Coinbase Credit Inc. secured by Bitcoin collateral, and the agreement in principle to settle a civil investigative demand from the U.S. Department of Justice. Other 8-K filings describe a strategic plan to realign operations through headcount reductions and expense curtailment, a non-executive retention program, executive officer changes and the Agreement and Plan of Merger providing for the acquisition of Semler Scientific by Strive, Inc. in an all-stock transaction.
Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, helping readers quickly identify items such as segment performance, digital asset disclosures, capital structure changes and merger-related information. Investors can also use the filings to monitor topics like BTC Yield as a disclosed key performance indicator, the structure of Bitcoin-related financing arrangements and other regulatory disclosures relevant to SMLR.
Strive, Inc. announced a proposed business combination with Semler Scientific and outlined next steps in the regulatory process. Strive intends to file an S-4 registration statement to register Class A common stock to be issued in the transaction, which will include an information statement, proxy statement for Semler Scientific stockholders, and a prospectus.
A definitive proxy/prospectus will be sent to Semler Scientific stockholders to seek approval of the proposed transaction. The communication includes a standard caution about forward-looking statements and directs investors to review the S-4 and related materials when available on the SEC’s website and the companies’ investor sites.
Strive, Inc. filed a Rule 425 communication regarding its proposed business combination with Semler Scientific, Inc.
Strive plans to file a Form S-4 to register Class A common stock to be issued in the transaction. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The communication includes a comprehensive forward‑looking statements caution.
Transaction materials will be available on the SEC’s website and the companies’ investor relations sites. The notice states it is not an offer or solicitation to buy or sell securities.
Strive, Inc. shared a Rule 425 communication about its proposed business combination with Semler Scientific (SMLR). The message, reposted on X by Strive’s CMO on October 24, 2025, includes a standard caution that forward‑looking statements involve risks and uncertainties. Strive plans to file a Form S-4 to register Class A common stock to be issued in the transaction, which will include an information statement/proxy statement/prospectus. Semler stockholders will receive materials to consider the proposal, and related documents will be available on the SEC’s website and the companies’ investor pages.
Semler Scientific (SMLR) announced a leadership change. On October 16, 2025, Renae Cormier resigned as Chief Financial Officer, principal financial officer, and principal accounting officer, effective October 30, 2025, to pursue another opportunity.
The board appointed President and CEO Dr. Douglas Murphy‑Chutorian to serve as interim Chief Financial Officer and as principal financial officer and principal accounting officer effective October 30, 2025. He will receive no additional compensation for these interim duties. Biographical information for Dr. Murphy‑Chutorian is incorporated by reference from the company’s July 17, 2025 proxy statement.
Strive, Inc. and Semler Scientific plan an all‑stock merger to combine as a Bitcoin Treasury company. In a Yahoo Finance interview included here, the discussion highlights a combined balance sheet with more than 10,000 Bitcoin and the goal of lowering operating costs through scale while pursuing strategies designed to outperform Bitcoin over time.
Strive’s CEO also described expanding Semler’s operating focus toward preventative healthcare, guided by experienced board members. To move forward, Strive will file a Form S‑4 registering the Class A common stock to be issued, and Semler stockholders will receive a proxy to vote on the proposed transaction. Investors are directed to review the forthcoming Registration Statement and related materials when available.
Semler Scientific filed an 8-K reporting a material event related to its pending merger and a financing arrangement. The filing lists potential risks that could prevent the merger from closing, including termination rights under the merger agreement, unmet closing conditions, litigation, failure to realize anticipated benefits (including risks from Bitcoin treasury strategies and digital assets), integration challenges, higher-than-expected transaction costs, management distraction, dilution from additional Class A share issuances, adverse customer or employee reactions, and share-price volatility. The filing also identifies an exhibit: a Master Loan Agreement dated April 15, 2025 among Coinbase Credit, Inc., Coinbase, Inc. and Semler Scientific, Inc., which appears to be a material financing document disclosed with the 8-K.
Semler Scientific, Inc. (SMLR) filed a Form 8-K reporting a material event related to a proposed transaction with Strive and Strive’s affiliate Semler Sci. The filing lists risks that could affect completion and outcomes of the merger agreement, including termination rights, failure to satisfy closing conditions, litigation, integration challenges, higher than expected transaction costs, diversion of management attention, dilution from issuing Class A common stock, adverse customer or employee reactions, and exposure to risks from Bitcoin treasury strategies and digital assets. The filing includes two exhibits: supplemental information dated September 22, 2025, and supplemental unaudited pro forma combined financial information.
Semler Scientific, Inc. (SMLR) disclosed a signed Agreement and Plan of Merger dated September 22, 2025, with Strive, Inc., and identified a range of transaction risks. The filing lists events that could let either party terminate the merger, and warns the deal may not close on schedule or at all if closing conditions are unmet. The company highlights potential integration challenges, higher-than-expected transaction costs, management distraction, customer or employee reactions, dilution from issuing additional Class A stock, share-price volatility, and specific risks tied to Bitcoin treasury strategies and digital-asset exposures. The filing is signed by CFO Renae Cormier.
Semler Scientific (SMLR) disclosed a material event relating to a proposed merger with Strive that includes a joint press release dated September 22, 2025. The filing lists key transaction risks: the merger could be terminated under certain events; closing may be delayed or fail if closing conditions are not met; legal proceedings could affect either party; anticipated benefits, including cost savings and strategic gains, may not materialize; integration could be harder or costlier than expected; management distraction and dilution from issuing additional Class A shares are possible; customers, employees, or market reactions could be adverse; and risks specific to implementation of Bitcoin treasury strategies and digital assets are highlighted. The filing also lists Exhibit 99.1 as the joint press release and is signed by Semler Scientific’s CFO, Renae Cormier.
Semler Scientific, Inc. (SMLR) is reported to have 787,030 shares beneficially owned by a group of affiliated reporting persons, representing 5.7% of the outstanding common stock based on 13,788,405 shares outstanding as of July 2, 2025. The filing lists five reporting entities — Capital Ventures International; Susquehanna Advisors Group, Inc.; G1 Execution Services, LLC; SIG Brokerage, LP; and Susquehanna Securities, LLC — and explains they may be deemed a group with shared voting and dispositive power. Susquehanna Securities reported inclusion of 248,900 options in its total. The filing includes addresses and certifications and is signed by Brian Sopinsky on behalf of the reporting persons.
FAQ
What is the current stock price of Semler Scientific (SMLR)?
What is the market cap of Semler Scientific (SMLR)?
